A trial looking at adding immunotherapy to rucaparib for ovarian cancer that has come back (Centurion)

This trial is looking at adding nivolumab to rucaparib to improve treatment for ovarian cancer. It is also looking at adding nivolumab and ipilimumab to rucaparib.

It is for women who are going to have treatment for one of the following:

• ovarian cancer

• fallopian tube cancer

• primary peritoneal cancer

Treatment for these cancers is the same. So when we use ovarian cancer in the summary, we are referring to all 3 cancers.

Cancer Research UK supports this trial.